Thyroid gland tumors from the view of the assessment physician
Authors:
M. Fialová
Authors‘ workplace:
3. chirurgická klinika 1. LF UK a FN Motol, Praha
Published in:
Reviz. posud. Lék., 24, 2021, č. 1, s. 7-18
Category:
Original Articles, Review Articles, Case Reports
Overview
A complex report on thyroid tumors current treatment options for thyroid cancer depending on its histological type and extent, focusing mainly on locally advanced and borderline operable findings. The treatment of such heterogeneous group of tumors usually requires long-term and multidisciplinary approach. Description of four interesting case reports with pictorial documentation, description of the course of treatment and assessment of disability.
Analysis and recommended evaluation of the percentage work ability reduction from the point of view of a medical assessor is provided for all individual case reports and compared against real assessments.
Keywords:
locally advanced thyroid cancer – tracheal resection – assessment medicine – percentage reduction in work ability
Sources
1. Vlček P. Radiojod-refrakterní karcinom štítné žlázy a správné načasování systémové léčby. Head and Neck Cancer News, 2020; 3: 6–11.
2. Kopečková K. Nádory štítné žlázy – diferencované karcinomy a medulární karcinom, Head and Neck Cancer News, 2020; 3: 4–5.
3. Švébišová H. Léčba pacientů se zhoubnými nádory štítné žlázy. Head and Neck Cancer News, 2020; 3: 13–15.
4. Jurečková A. Diferencovaný a medulární karcinom štítné žlázy. Head and Neck Cancer News, 2020; 3: 22.
5. Králík R. Aktuálne trendy v chirurgickej liečbe nádorov štítnej žľazy. Onkológia, Bratislava 2015; 10(5): 278–281.
6. Cooper D, et al. Revised American Thyroid Association Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA)guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19[11]:1167−1214. doi:10.1089/ thy.2009.0110.
7. Gimm O., Dralle H. Lymphadenektomie beim Schildrusen- and Nebenschilddrusenkarzinom. Chirurg, 2007;78:182−193.
8. Dralle H, et al. Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival. Surgery 2010;148(6):1257−1266.
9. Cooper D, et al. Revised American Thyroid Association management guidelines for patiens with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:11.
10. Dvořák J. Štítná žláza, chirurgická anatomie, operační technika. 2. vyd. Serifa Praha 2002;244–252.
11. Webový portál – Epidemiologie zhoubných nádorů v České republice. http://www.svod.cz/ Report diagnózy: C73 - ZN štítné žlázy https://www.svod.cz/report.php?diag=C73&type=pdf.
12. Kraus J., Plzák J., Kastner J. Chirurgická léčba nádorů hlavy a krku – část I. Konference 2005 VIII. setkání Klubu mladých onkologů: 19, https://www.linkos.cz/lekar-a-multidisciplinarni- tym/kongresy/po-kongresu/databaze-tuzemskych-onkologickych-konferencnich-abstrakt/chirurgicka-lecba-nadoru- hlavy-a-krku-cast-i/.
13. Glover A, Gundara J, Norlén O, et al. The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma. Gland Surg, 2013;2[4]:196–205. doi: 10.3978/j.issn.2227- 684X.2013.10.05.
14. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (online), 2014 URL: < http://www. nccn.org/professionals/physician_gls/pdf/thyroid.pdf>[cit. 2014-12-15].
15. Shimaoka K, Schoenfeld D, DeWys W, et al. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer, 1985;56:2155–60.
16. De Besi P, Busnardo B, Toso S, et al. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest., 1991;14:475–80.
17. Schlumberger M, Abdelmoumene A, Delisle M. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d’Etude des Tumeurs a Calcitonine (GETC). Br J Cancer. 1995;71:363–365.
18. Smallridge R, Ain K, Asa S, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 2012, Nov;22(11):1104–1139.
19. Haugen B, Alexander E, Bible K, et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016;26[1]:1–133.
20. Azrif M, Slevin N, Sykes A. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol., 2008;89:105–113.
21. Bellantone R, Boscherini M, Lombardi C. Medullary thyroid carcinoma: surgical management of primary tumor and locoregional recurrence. Rays, 2000;25:267–271.
22. Kebebew E, Greenspan F, Clark O, et al. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer, 2005;103:1330–1335.
23. De Crevoisier R, Baudin E, Bachelot A, et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys., 2004; 60:1137–1143.
24. Smallridge R, Ain K, Asa S, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 2012; 22(11):1104–1139.
25. Sociální pojištění 2020 úplné znění, č. 1355, vyhláška č. 359/2009 Sb., s. 218–225.
Labels
Medical assessment Occupational medicineArticle was published in
Medical Revision
2021 Issue 1
Most read in this issue
- Thyroid gland tumors from the view of the assessment physician
- Ke schopnosti zvládat základní životní potřeby
- Revision medicine in the turbulent time
- Pastorková R.: The use of electronic quarantine records during the COVID-19 pandemic